Maryland [US], July 30 (ANI): During a recent study, researchers found that a combination of the immunotherapy drug nivolumab and the kinase-inhibitor drug cabozantinib can make curative surgery possible in some liver cancer patients who would normally not be considered surgical candidates.
Washington [US], June 4 (ANI): Researchers at the Memorial Sloan Kettering Cancer Center (MSK) found that patients who received nivolumab after bladder cancer surgery reduced their overall risk for high-grade bladder cancer recurrence. This research was published in the journal New England J
Washington D.C. [USA], Sept 29 (ANI): In a new trial, researchers have discovered that a combination of two immunotherapy drugs -- ipilimumab and nivolumab - is capable of reversing or preventing the progression of advanced melanoma for five years or more in one in every two patients.
Washington D.C. [U.S.A], Oct. 8 (ANI): In a recent study, a group of researchers found a link between an individual's gut bacteria and their response to anticancer immune checkpoint inhibitor therapy (ICT).